healthcare News
Weight-Loss Drug Stocks Tumble on Trump Pricing Pressure Report
Novo Nordisk and Eli Lilly shares fall after a report details potential negotiations to slash U.S. drug prices by nearly 90%, threatening a high-growth sector.
Eli Lilly Taps Walmart to Expand Zepbound Retail Access
The partnership leverages Walmart's vast pharmacy network for Lilly's direct-to-consumer platform, intensifying the battle for the multi-billion-dollar weight-loss drug market.
Novartis' Leqvio study shows promise in cholesterol treatment
Phase IV trial data reveals the drug helps patients achieve LDL-C goals with reduced muscle pain, bolstering its market position.
Alnylam, Roche Advance Hypertension Drug to Pivotal Phase 3 Trial
Zilebesiran, a twice-yearly injection, will be tested in 11,000 high-risk patients following promising mid-stage results.
Amarin Surges on Positive VASCEPA Trial Data
New analyses from the REDUCE-IT trial show a 9% reduction in hospitalizations, bolstering the drug's profile amid ongoing generic competition.
BridgeBio Drug Acoramidis Shows 44% Cut in Heart-Related Deaths
Long-term study data presented at a major cardiology conference reinforces the drug's potential in treating a rare heart condition.
MSP Recovery Secures $55M Lifeline at a Heavy Cost to Shareholders
Financing deal carries risk of 46% equity dilution, coupled with a 1-for-7 reverse stock split to maintain Nasdaq listing.
Cytokinetics Drug Bests Standard Care in Heart Study
Aficamten proves superior to metoprolol for hypertrophic cardiomyopathy, positioning the drug for a potential shift in treatment standards.